JBC Biosymposia, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M408840200 on August 19, 2004

J. Biol. Chem., Vol. 279, Issue 43, 45219-45225, October 22, 2004
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/43/45219    most recent
M408840200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sugawara, H.
Right arrow Articles by Hatakeyama, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sugawara, H.
Right arrow Articles by Hatakeyama, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Characteristic Recognition of N-Acetylgalactosamine by an Invertebrate C-type Lectin, CEL-I, Revealed by X-ray Crystallographic Analysis*

Hajime Sugawara{ddagger}§, Masami Kusunoki{ddagger}, Genji Kurisu{ddagger}, Tokiko Fujimoto||, Haruhiko Aoyagi||, and Tomomitsu Hatakeyama||**

From the {ddagger}Research Center for Structural and Functional Proteomics, Institute for Protein Research, Osaka University, 3-2 Yamada-oka, Suita, Osaka 565-0871, Japan, the §Laboratory for Communication Mechanisms, RIKEN Plant Science Center, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan, and the ||Department of Applied Chemistry, Faculty of Engineering, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki 852-8521, Japan

Received for publication, August 3, 2004 , and in revised form, August 19, 2004.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
 REFERENCES
 
CEL-I is a C-type lectin, purified from the sea cucumber Cucumaria echinata, that shows a high specificity for N-acetylgalactosamine (GalNAc). We determined the crystal structures of CEL-I and its complex with GalNAc at 2.0 and 1.7 Å resolution, respectively. CEL-I forms a disulfide-linked homodimer and contains two intramolecular disulfide bonds, although it lacks one intramolecular disulfide bond that is widely conserved among various C-type carbohydrate recognition domains (CRDs). Although the sequence similarity of CEL-I with other C-type CRDs is low, the overall folding of CEL-I was quite similar to those of other C-type CRDs. The structure of the complex with GalNAc revealed that the basic recognition mode of GalNAc was very similar to that for the GalNAc-binding mutant of the mannose-binding protein. However, the acetamido group of GalNAc appeared to be recognized more strongly by the combination of hydrogen bonds to Arg115 and van der Waals interaction with Gln70. Mutational analyses, in which Gln70 and/or Arg115 were replaced by alanine, confirmed that these residues contributed to GalNAc recognition in a cooperative manner.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
 REFERENCES
 
Carbohydrate-binding proteins (lectins) have been shown to play important roles in molecular recognition processes in various tissues and body fluids. There are increasing numbers of animal lectins (1, 2), which are categorized into several families according to their structural homologies. Various proteins that display carbohydrate-binding activity in a Ca2+-dependent manner are classified into the C-type lectin family (3). They contain C-type carbohydrate-recognition domains (CRDs)1 composed of 110–130 amino acid residues in common. In vertebrate C-type lectins, the C-type CRDs mostly occur as carbohydrate-binding modules linked to other domains with distinct functions. They fall into seven groups (4) and function through cooperation of the CRDs with other individual domains. In contrast, invertebrate C-type lectins are mostly single-domain proteins. One of their possible roles is thought to be inactivation or opsonization of foreign microorganisms in place of immunoglobulins in vertebrates. There are only limited numbers of C-type CRDs whose tertiary structures have been determined. Mannose-binding protein (MBP) was the first C-type lectin for which a crystal structure was determined (5). This protein contains an N-terminal collagenous domain, followed by a link domain and a C-type CRD. The latter two domains have been expressed in a recombinant form, and the structure as well as various mutant forms have been analyzed by x-ray crystallography (610). In addition to MBP, the crystal structures of CRDs complexed with carbohydrates have been solved for DC-SIGN, DC-SIGNR (11), P- and E-selectins (12), tunicate lectin TC14 (13), and rattlesnake venom lectin RSL (14). In addition to these lectins, several C-type lectin-like domains (CTLD) without carbohydrate-binding ability have also been found (2). These lack the essential residues for carbohydrate binding, and instead many are thought to function as receptors for noncarbohydrate ligands. Although these proteins share only slight sequence similarity (~20%), their tertiary structures are basically similar to each other (15).

We previously isolated four Ca2+-dependent galactose/N-acetylgalactosamine-specific lectins (CEL-I, -II, -III, and -IV) from the marine invertebrate Cucumaria echinata (Holothuroidea) (16). Based on their amino acid sequences, CEL-I and CEL-IV are clearly categorized into the C-type lectin family, whereas CEL-III is a novel Ca2+-dependent lectin with strong hemolytic activity as well as cytotoxicity (1720). CEL-III shows sequence similarity with {beta}-trefoil lectins, such as the B-chains of ricin and abrin (21). The similarity of the three-dimensional structure of CEL-III with these proteins has recently been revealed by x-ray crystallographic analysis (22). CEL-I, which is the smallest lectin in C. echinata, is composed of two identical 16-kDa subunits linked by a single interchain disulfide bond (23). CEL-I has very high specificity for N-acetylgalactosamine (GalNAc), and its affinity for GalNAc is ~1000-fold stronger than that for galactose as judged by hemagglutination inhibition assays. To date, no other C-type lectins with such high specificity for GalNAc have been identified. It is therefore of great interest to clarify the CEL-I-specific carbohydrate-recognition mechanism not only to understand the carbohydrate-recognition mechanism of C-type lectins but also the structural basis to design molecules with novel carbohydrate-specific affinity. We previously obtained single crystals of CEL-I that were suitable for x-ray diffraction studies (24). Recently, we also succeeded in crystallizing the CEL-I-GalNAc complex. In this report, we describe x-ray crystallographic analyses of CEL-I and the CEL-I-GalNAc complex to elucidate the mechanism of its high specificity for GalNAc along with the site-directed mutagenesis experiments of a recombinant CEL-I (rCEL-I) that was expressed in Escherichia coli cells.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
 REFERENCES
 
Purification of CEL-I—CEL-I was purified from C. echinata according to a previously reported method (19). The proteins extracted from a homogenate of C. echinata were applied to a lactose-Cellulofine column equilibrated with 0.15 M NaCl, 10 mM Tris-HCl, pH 7.5, (TBS) containing 10 mM CaCl2. Adsorbed lectins (CEL-I, -III, and -IV) were eluted with TBS containing 20 mM EDTA. The lectins were then separated using a GalNAc-Cellulofine column utilizing the differences in their carbohydrate-binding specificities. After elution of CEL-III with TBS containing 0.1 M lactose, CEL-I and CEL-IV were eluted with TBS containing 20 mM EDTA. CEL-I and CEL-IV were finally separated by gel filtration through Sephadex G-75 in TBS.

Crystallizations and Data Collection—The purification and crystallization of native CEL-I have already been reported (24). Briefly, the protein solution (5 mg/ml, 2–4 µl) in TBS was mixed with the same amount of reservoir solution (0.1 M Tris-HCl, pH 8.0, 60% MPD), and subjected to hanging or sitting drop vapor diffusion at 20 °C. X-ray data collection was performed on beamline BL-18B at the High Energy Acceleration Research Organization, Tsukuba, Japan, using an ADSC Quantum 4R CCD camera (25). The space group was monoclinic C2 with unit cell parameters of a = 92.4, b = 69.9, c = 76.7 Å, and {beta} = 136.5°. Reduction of a total of 72,844 reflections from CEL-I crystals yielded 19,924 independent reflections with 92.3% completeness for a resolution range of 52.7–2.0 Å and an overall Rmerge of 6.1%. CEL-I-GalNAc complex crystals were prepared under essentially the same conditions as the native crystals except for the addition of 1 mM GalNAc to the samples. Because the complex crystals were initially formed as spherulites, these were used as seeds for a microseeding method. Single crystals of the CEL-I-GalNAc complex grew to sufficient sizes for data collection within one month. Data collection was performed at 100 K using a Rigaku R-AXIS VII imaging plate area detector equipped with a Rigaku FR-E SuperBright rotating-anode generator. Image data were processed by the programs MOSFLM (26) and SCALA (27). The space group and unit cell parameters of the CEL-I/GalNAc crystals were determined to be P21 and a = 39.6, b = 52.2, c = 136.6, and {beta} = 91.7°, respectively. Assuming two molecules of CEL-I, each composed of a homodimer in the asymmetric unit, the value of the Matthews constant, Vm (28), is 2.20 Å3 Da-1 corresponding to a solvent content of 44.2%. The final data for the CEL-I-GalNAc complex crystals comprised 59,176 independent reflections with 96.3% completeness for a range of 33.8–1.7 Å and an overall Rmerge of 6.2%. The completeness and Rmerge for the highest resolution shell (1.79–1.70 Å) were 84.9 and 16.2%, respectively.

Structure Determination and Refinement—The crystal structures of native CEL-I and the CEL-I-GalNAc complex were solved by the molecular replacement method. The search model for native CEL-I was based on the human lithostathine structure (PDB code 1LIT [PDB] ) (29), which shares 28% amino acid sequence identity with CEL-I. Molecular replacement calculations were performed using the program AMoRe (30) from the CCP4 suite (26). The model was refined using the program CNS (31) with noncrystallographic symmetry restraints. Five percent of the reflections were set aside for Rfree calculations (32). Manual fitting of the model was carried out by the program Xfit (33). The final R and Rfree factors for all reflections between 52.7- and 2.0-Å resolution for native CEL-I were 0.140 and 0.179, respectively. The structure of the CEL-I-GalNAc complex was also solved by the molecular replacement method using the native CEL-I coordinates as a search model. The positions and orientations of GalNAc in the complex were clearly shown by the Fo - Fc difference Fourier map with a contour level of 3{sigma}. The model was finally refined by the program REFMAC (34) without noncrystallographic symmetry restraints. The final R and Rfree factors between 33.8- and 1.7-Å resolution for the CEL-I-GalNAc complex were 0.158 and 0.186, respectively. The quality of the final models for native and complexed CEL-I was assessed by Ramachandran plots and analysis of the model geometry with the program PROCHECK (35). The crystallographic statistics are summarized in Table I.


View this table:
[in this window]
[in a new window]
 
TABLE I
Refinement statistics

 
Expression of Recombinant CEL-I—Wild-type rCEL-I was constructed from an artificial synthetic gene as reported previously (36). The rCEL-I gene was inserted into the pET-3a vector (Novagen), and used to transform E. coli BL21(DE3)pLysS (Novagen). The proteins were expressed as inclusion bodies, which were solubilized with 20 mM Tris-HCl buffer, pH 8.5, containing 8 M urea and 1% 2-mercaptoethanol. The solubilized protein was purified by chromatography through a DEAE-Cellulofine column in 20 mM Tris-HCl, pH 8.5, containing 4 M urea and elution with a NaCl gradient from 0 to 0.5 M. The rCEL-I was pooled and dialyzed against TBS, and the active protein was separated by affinity chromatography through a GalNAc-Cellulofine column (18). DNAs encoding mutant proteins, in which Arg115 and/or Gln70 were replaced by Ala (R115A, Q70A and Q70A/R115A), were prepared by polymerase chain reaction using two oligonucleotides (30mers) containing the mutation site and the plasmid containing wild-type rCEL-I DNA as a template. The mutant proteins were purified by the same procedure used for the wild-type protein. The N-terminal sequences of these proteins were confirmed using a Shimadzu PPSQ-21 protein sequencer.

Hemagglutination Assay—Serial 2-fold dilutions of a sample (50 µl) were mixed with the same volume of a 5% (v/v) suspension of rabbit erythrocytes in the wells of round bottomed microtiter plates. Incubation was performed in TBS containing 10 mM CaCl2. The extent of agglutination was examined visually after incubation for 1 h at room temperature. The hemagglutinating activity was expressed as a titer, i.e. the reciprocal of the highest dilution producing detectable agglutination. Hemagglutination inhibition assays were performed by incubating 50-µl aliquots of the protein solutions (titer 2) containing various concentrations of carbohydrates with the same volume of a 5% (v/v) suspension of rabbit erythrocytes in TBS containing 10 mM CaCl2.


    RESULTS AND DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
 REFERENCES
 
The crystal structure of CEL-I was solved by the molecular replacement method using human lithostathine, which contains a CTLD (29), as a search model. Native CEL-I is composed of one disulfide-linked homodimer (protomers A and B) in each asymmetric unit (Fig. 1). As shown in other C-type CRDs, the three-dimensional structure of CEL-I consists of two parts, a lower part composed of two {alpha}-helices ({alpha}1 and {alpha}2) and four {beta}-strands ({beta}0, {beta}1, {beta}1', and {beta}5), and an upper part composed of four {beta}-strands ({beta}2, {beta}2', {beta}3, and {beta}4), the latter of which contains the calcium-binding sites (Figs. 1 and 2). Regardless of the low sequence similarity (16–30%) with other C-type CRDs and CTLDs, structural comparison with known three-dimensional structures by DALI (37) revealed that CEL-I is very similar to long form CTLDs, such as lithostathine (Z = 21.6, r.m.s.d. of 1.7 Å for 128 C{alpha} atoms), the H1 subunit of the asialoglycoprotein receptor (Z = 19.6, r.m.s.d. of 1.3 Å for 118 C{alpha} atoms), and tetranectin (Z = 19.5, r.m.s.d. of 2.1 Å for 132 C{alpha} atoms). CEL-I also shows similarity with short form CTLDs, such as MBP-A (Z = 17.5, r.m.s.d. of 2.1 Å for 123 C{alpha} atoms) and tunicate lectin TC14 (Z = 15.8, r.m.s.d. of 2.2 Å for 117 C{alpha} atoms). Compared with other CRDs, CEL-I has an insertion (residues 36–41) between {alpha}1 and {beta}1' containing a 310 helix (residues 37–39) (Fig. 3).



View larger version (37K):
[in this window]
[in a new window]
 
FIG. 1.
Stereo view of the ribbon model of CEL-I (protomer A). The {alpha}-helices, {beta}-strands, loops, and intramolecular disulfide bonds are shown in purple, blue, gray, and green, respectively. Bound calcium ions are shown by cyan spheres. Secondary structures were determined by the program PROMOTIF (45). Fig. 1 was drawn by the program MOLSCRIPT (46) and rendered by the program Raster3D (47).

 



View larger version (19K):
[in this window]
[in a new window]
 
FIG. 2.
Ca2+-binding modes of CEL-I. Carbon and calcium atoms are shown in green. Oxygen and nitrogen atoms are shown in red and blue, respectively. Hydrogen and coordination bonds are indicated by dots. A, CA1 and CA3 of protomer A. The main-chain carbonyl group of the symmetry-related Gly93 in protomer B is illustrated in orange. B, CA2 of protomer A. An MPD molecule coordinating with CA2 is also shown. Hydrogen bonds between the MPD and CEL-I molecules are illustrated by dots and were determined by the program HBPLUS (48). Fig. 2 was drawn by the program PyMOL (49).

 



View larger version (23K):
[in this window]
[in a new window]
 
FIG. 3.
Sequence alignment and secondary structure of CEL-I and other C-type lectins. Three invertebrate CRDs (CEL-I, tunicate, and starfish lectins) and a GalNAc-binding (QPDWGH) mutant of MBP (10) were aligned. The colors for the secondary structures are the same as those described in the legend to Fig. 1. Conserved residues are illustrated in red. Conserved residues among both the galactose- and mannose-binding types and the galactose-binding type only of the C-type lectins are shown in yellow and orange, respectively. Cysteine residues widely conserved among CTLDs are shown in green. The structure-based sequence alignment was performed by DALI (37), except for the GalNAc-specific binding starfish lectin. The residues that coordinate with carbohydrate-binding Ca2+ ions are boxed in blue. This figure was drawn by the program ALSCRIPT (50) and manually modified.

 
There are two intramolecular disulfide bonds in CEL-I (Cys3–Cys14 and Cys31–Cys135). The bond between Cys31 and Cys135 is equivalent to a widely conserved disulfide bond among CTLDs, whereas that between Cys3 and Cys14 is only observed in long form C-type CRDs (38). However, CEL-I does not have a disulfide bond connecting {beta}3 and the loop between {beta}4 and {beta}5, which is well conserved in CTLDs. In CEL-I, the corresponding cysteine residues are replaced by Tyr111 and Ala127 (Fig. 3). The space resulting from the lack of this disulfide bond is filled by Tyr111, which may contribute to the stabilization of the protein structure instead of the corresponding disulfide bond.

The two identical protomers of CEL-I are linked by an interchain disulfide bond between the Cys36 residues (Fig. 4A). In addition to this disulfide bond, there are several interactions between the two subunits around the N-terminal (residues 1–4), C-terminal (residues 137–140), and insertion loop (residues 36–41) (Fig. 5). Eight hydrogen bonds are present between the two protomers (Gln2–Gln2, Gln2–Gly11, Glu140–Thr5, Tyr34 (protomer A)–Thr38 (protomer B) and Thr38 (protomer A)–Ser35 (protomer B)). In particular, Gln2 appears to be especially important for dimeric interactions, because the O{epsilon}-1 and N{epsilon}-2 atoms of its side chain in one subunit make hydrogen bonds to the main-chain amide group of Gln2 and the main-chain carbonyl group of Gly11 in the other subunit, respectively (Fig. 5A). There are also hydrophobic interactions between the two subunits through Pro4, Leu39, Val41, Leu137, and Phe139 (Fig. 5B). Among the available C-type lectin crystal structures, only tunicate lectin TC14 has a homodimeric structure composed of two C-type CRDs (39). The two subunits of the TC14 homodimer associate with each other through noncovalent interactions between {beta}-strands and {alpha}-helices (Fig. 4B), because two N-terminal {beta}-strands ({beta}1) make an anti-parallel {beta}-sheet, and two {alpha}-helices ({alpha}2) associate by hydrophobic interactions. Recently, another C-type CRD linked by intermolecular disulfide bonds has been reported in the decameric structure of rattlesnake venom lectin RSL (14). Meanwhile, the coagulation factor-binding proteins also form a disulfide-linked dimer composed of CTLDs, which have long loops to make dimeric interactions (40, 41)



View larger version (33K):
[in this window]
[in a new window]
 
FIG. 4.
Homodimeric structures of CEL-I and TC14. A, CEL-I molecule. B, TC14 molecule. The colors are the same as those described in the legend to Fig. 1. In the top figures, pseudo 2-fold axes pass through the center of the two protomers perpendicular to the paper. The bottom figures were obtained by a 90-degree rotation around the horizontal line at the center of the top figures. Fig. 4 was drawn by the program MOLSCRIPT (46) and rendered by the program Raster3D (47).

 



View larger version (25K):
[in this window]
[in a new window]
 
FIG. 5.
Dimeric interactions of CEL-I. Hydrophilic (A) and hydrophobic (B) interactions connecting the two subunits of CEL-I. Pseudo 2-fold axes pass through the center of the two protomers. Only the residues forming each hydrophilic and hydrophobic interaction are shown. The subunits in pink and blue represent protomer A and protomer B, respectively. Oxygen and nitrogen atoms of the illustrated side chains and the backbone atoms are shown in red and blue, respectively. Hydrogen bonds are indicated by yellow dots. Fig. 5 was drawn by the program PyMOL (49).

 
Three Ca2+ ions (designated CA1, CA2, and CA3) are present in each subunit (Fig. 2). They are bound in a similar way to those of MBP-A (6), lung surfactant protein D (42), DC-SIGN, and DC-SIGNR (11). CA1 is coordinated by the side chains of Asp77, Glu81, Asn104, and Asp110, the main-chain carbonyl oxygen of Glu109, and one molecule of water (Fig. 2A). CA2 is coordinated by the side chains of Gln101, Asp103, Glu109, Asn123, and Asp124 and the main-chain carbonyl oxygen of Asp124 (Fig. 2B). In addition, two hydroxyl groups of MPD, used as a precipitant for crystallization, coordinate with CA2. They also form hydrogen bonds with the side chains of Gln101, Asp103, Glu109, and Asn123, and the main-chain carbonyl oxygen of Asp124. CA3 shares the side chains of Glu81 and Asp110 with CA1, and the other ligands for CA3 are the main-chain carbonyl group of Gly93 in the symmetry-related protomer B (only for CA3 in protomer A) and three water molecules (Fig. 2A).

There are two CEL-I homodimer molecules (the subunit structure is designated 1A/1B and 2A/2B for each molecule) in the asymmetric unit of the CEL-I-GalNAc complex crystal. Four bound GalNAc molecules coordinate to CA2 with their 3-OH and 4-OH in place of the two hydroxyl groups of MPD found in the native CEL-I crystal (Fig. 6A). These hydroxyl groups also form hydrogen bonds with the side chains of Gln101, Asp103, Glu109, and Asn123. This binding mode is basically consistent with those of the carbohydrate complexes of MBP-C (9) and the GalNAc-binding mutant of MBP (10) (Fig. 6B). Although the indole rings of Trp105 in protomers 1B and 2B are flipped relative to those in protomers 1A and 2A, because of the hydrogen-bonding with the main-chain carbonyl oxygen of Gln101 in the symmetry-related molecule of protomers 1B and 2B, the Trp105 residues in all protomers make van der Waals contact with the C-6 atom of GalNAc, thereby stabilizing the binding of GalNAc. Tryptophan residues have been found to stabilize the binding of carbohydrates in the Gal/GalNAc-recognizing C-type CRDs (7, 13). However, the interaction between Trp105 and the C-6 atom of GalNAc appears to be relatively weak in the case of CEL-I, compared with that of Trp189 in the GalNAc-binding mutant of MBP, which makes van der Waals contacts with the C-3, C-4, C-5, and C-6 carbon atoms of GalNAc (Fig. 6B). In the mutant MBP, five residues (192–196) inserted as a glycine-rich loop (7) appear to lead to closer contact between Trp189 and GalNAc.



View larger version (44K):
[in this window]
[in a new window]
 
FIG. 6.
Comparison of the carbohydrate-binding modes of CEL-I and the GalNAc-binding mutant of MBP. A, electron density map around the GalNAc-binding site of CEL-I (protomer 1A). A 2Fobs - Fcalc omit map is drawn at the 1.5{sigma} level. Carbon, oxygen, nitrogen, and calcium atoms are shown in green, red, blue, and purple, respectively. B, overlapped structures of CEL-I (protomer 1A) and the mutant MBP around the bound GalNAc. C, overlapped structures of CEL-I (protomer 1A) and the mutant MBP around the acetamido group. GalNAc, the calcium ion, and its binding residues in CEL-I and the MBP mutant are superimposed. Carbon, calcium atoms, and residue numbers of CEL-I and the mutant MBP are shown in green and yellow, respectively. Hydrogen and coordination bonds are indicated by dots. The GalNAc-binding site structure of protomer 2A is similar to this site. Fig. 6 was drawn by the program PyMOL (49).

 
In the case of the CEL-I-GalNAc complex, there are two hydrogen bonds between the guanidium group of Arg115 and the carbonyl oxygen of the acetamido group of GalNAc (Fig. 6C). An arginine residue (Arg122) corresponding to Arg115 in CEL-I has been found in starfish (Asterina pectinifera) lectin, which also specifically binds to GalNAc (43). In addition, the acetamido group of GalNAc also makes van der Waals contacts with the side chains of Gln70 and Asn123 (Fig. 6C). Therefore, these interactions are assumed to be closely related to the high affinity binding of GalNAc to CEL-I. CEL-I binds to the {beta}-anomer of GalNAc, except for protomer 1B which preferentially binds the {alpha}-anomer because of a hydrogen bond between 1-OH of the bound GalNAc and Asp83 in protomer 2A. In protomers 1A and 2A, the terminal NH2 group of the side chain of Arg115 also makes a hydrogen bond with 1-OH of GalNAc, which preferentially stabilizes the binding of the {beta}-anomer of GalNAc (Fig. 6C). Because Asn123 is essential as a ligand for CA2, we constructed mutants of rCEL-I, in which Arg115 and/or Gln70 were replaced by alanine (R115A, Q70A, and Q70A/R115A), to evaluate the contributions of these residues to GalNAc recognition. As reported previously, the wild-type rCEL-I expressed in E. coli cells exhibited a very similar, although slightly lower affinity, carbohydrate-binding specificity to the native protein in hemagglutination inhibition assays (36). Therefore, we evaluated the carbohydrate-binding specificity of the CEL-I mutants through the inhibition of hemagglutination by several simple carbohydrates. As shown in Table II, hemagglutination was inhibited by galactose-related carbohydrates in the wild-type as well as the mutant rCEL-I. In particular, GalNAc exhibited much stronger inhibition than the other carbohydrates (more than 250-fold in the case of the wild-type). However, inhibition by GalNAc decreased to ~1/8, 1/32, and 1/64 for the R115A, Q70A, and Q70A/R115A mutants, respectively, compared with the wild-type. On the other hand, other galactose and galactose-containing carbohydrates showed only slight changes in their inhibitory profiles, compared with the wild-type. This confirms that Arg115 and Gln70 make significant contributions to the recognition of GalNAc. In particular, Gln70 appears to be more important than Arg115 despite hydrogen bonds between the latter and GalNAc. As shown in Table II, the Q70A/R115A mutant still had the same affinity for Gal as well as a moderately high affinity for GalNAc. This indicates that Gln70 and Arg115 have little influence on the recognition of the galactose moiety and also suggests that other residue(s), such as Asn123, may be involved in recognizing the acetamido group of GalNAc in addition to Gln70 and Arg115.


View this table:
[in this window]
[in a new window]
 
TABLE II
Carbohydrate-binding specificities of wild-type and mutant CEL-I, as evaluated by hemagglutination inhibition assay The values in parentheses denote the ratio to those for the wild-type.

 
A GalNAc-binding mutant of MBP was constructed based on sequence comparison with rat hepatic lectin, which shows higher affinity for GalNAc than for Gal (44), and its complex structure with GalNAc was reported (10). Its preferential affinity for GalNAc compared with that for Gal is achieved by van der Waals contact between the methyl group of the acetamido group of GalNAc and the C{epsilon}-1 and N{epsilon}-2 atoms of His202, which was introduced in place of threonine, the corresponding amino acid in rat hepatic lectin. This MBP mutant attained a 60-fold higher affinity for GalNAc than for Gal, indicating that such van der Waals interactions are very important. As shown in Fig. 6, B and C, the orientation of GalNAc bound to CEL-I is very similar to that in the GalNAc-binding mutant of MBP. In the case of CEL-I, the methyl group of the acetamide of GalNAc makes van der Waals contact with Gln70 as mentioned above. Therefore, it appears that Gln70 may play a similar role to His202 in the GalNAc-binding mutant of MBP. On the other hand, Gln113, which is located at the corresponding position to His202 in the MBP mutant, may have the potential to interact with the methyl group of GalNAc, although a mutational analysis investigating this was not performed in the present study.

CEL-I exhibits strong cytotoxicity (36), which suggests an actual biological role for this protein as a defense toxin against predators. The toxicity is inhibited in the presence of GalNAc suggesting that it is mediated by binding to specific carbohydrate chains on the cell surface. One probable mechanism is that the binding of CEL-I to cell surface carbohydrate chains triggers intracellular signaling, leading to cell death. An identification of the natural carbohydrate ligands for CEL-I that are present on the target cell surface seems to be important for understanding the cytotoxicity at the molecular level. Further investigation of the involvement of the residues around the carbohydrate-binding site of CEL-I using recombinant proteins should provide important clues regarding the recognition mechanism for natural ligands on the target cell surface.


    FOOTNOTES
 
The atomic coordinates and structure factors (codes 1WMY [PDB] and 1WMZ [PDB] ) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

Present address: Dept. of Life Sciences, Graduate School of Arts and Sciences, University of Tokyo, Komaba 3-8-1, Meguro-ku, Tokyo 153-8902, Japan. Back

** To whom correspondence should be addressed. Tel.: 81-95-819-2686; Fax: 81-95-819-2684; E-mail: thata{at}net.nagasaki-u.ac.jp.

1 The abbreviations used are: CRD, carbohydrate recognition domain; CTLD, C-type lectin-like domain; MBP, mannose-binding protein; MPD, 2-methyl-2,4-pentanediol; rCEL-I, recombinant CEL-I; DC-SIGN, dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin; DC-SIGNR, DC-SIGN-related molecule; TBS, Tris-buffered saline; r.m.s.d., root mean square deviation. Back


    ACKNOWLEDGMENTS
 
We thank Dr. N. Sakabe of the Foundation for Advancement of International Science and Drs. N. Watanabe, M. Suzuki, and N. Igarashi of the National Laboratory for High Energy Physics for their kind help in the data collection at the Photon Factory. This study was performed under the Cooperative Research Program of the Institute for Protein Research, Osaka University.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
 REFERENCES
 

  1. Gabius, H. J. (1997) Eur. J. Biochem. 243, 543-576[Medline] [Order article via Infotrieve]
  2. Dodd, R. B., and Drickamer, K. (2001) Glycobiol. 11, 71R-79R[Abstract/Free Full Text]
  3. Drickamer, K. (1988) J. Biol. Chem. 263, 9557-9560[Free Full Text]
  4. Day, A. J. (1994) Biochem. Soc. Trans. 22, 83-88[Medline] [Order article via Infotrieve]
  5. Weis, W. I., Kahn, R., Fourme, R., Drickamer, K., and Hendrickson, W. A. (1991) Science 254, 1608-1615[Abstract/Free Full Text]
  6. Weis, W. I., Drickamer, K., and Hendrickson, W. A. (1992) Nature 360, 127-134[CrossRef][Medline] [Order article via Infotrieve]
  7. Iobst, S. T., and Drickamer, K. (1994) J. Biol. Chem. 269, 15512-15519[Abstract/Free Full Text]
  8. Kolatkar, A. R., and Weis, W. I. (1996) J. Biol. Chem. 271, 6679-6685[Abstract/Free Full Text]
  9. Ng, K. K., Drickamer, K., and Weis, W. I. (1996) J. Biol. Chem. 271, 663-674[Abstract/Free Full Text]
  10. Kolatkar, A. R., Leung, A. K., Isecke, R., Brossmer, R., Drickamer, K., and Weis, W. I. (1998) J. Biol. Chem. 273, 19502-19508[Abstract/Free Full Text]
  11. Feinberg, H., Mitchell, D. A., Drickamer, K., and Weis, W. I. (2001) Science 294, 2163-2166[Abstract/Free Full Text]
  12. Somers, W. S., Tang, J., Shaw, G. D., and Camphausen, R. T. (2000) EMBO J. 19, 467-479
  13. Deleted in proof
  14. Walker, J. R., Nagar, B., Young, N. M., Hirama, T., and Rini, J. M. (2004) Biochemistry 43, 3783-3792[CrossRef][Medline] [Order article via Infotrieve]
  15. Swaminathan, G. J., Weaver, A. J., Loegering, D. A., Checkel, J. L., Leonidas, D. D., Gleich, G. J., and Acharya, K. R. (2001) J. Biol. Chem. 276, 26197-26203[Abstract/Free Full Text]
  16. Hatakeyama, T., Kohzaki, H., Nagatomo, H., and Yamasaki, N. (1994) J. Biochem. (Tokyo) 116, 209-214[Abstract/Free Full Text]
  17. Oda, T., Tsuru, M., Hatakeyama, T., Nagatomo, H., Muramatsu, T., and Yamasaki, N. (1997) J. Biochem. (Tokyo) 121, 560-567[Free Full Text]
  18. Hatakeyama, T., Furukawa, M., Nagatomo, H., Yamasaki, N., and Mori, T. (1996) J. Biol. Chem. 271, 16915-16920[Abstract/Free Full Text]
  19. Hatakeyama, T., Nagatomo, H., and Yamasaki, N. (1995) J. Biol. Chem. 270, 3560-3564[Abstract/Free Full Text]
  20. Oda, T., Shinmura, N., Nishioka, Y., Komatsu, N., Hatakeyama, T., and Muramatsu, T. (1999) J. Biochem. (Tokyo) 125, 713-720[Abstract/Free Full Text]
  21. Nakano, M., Tabata, S., Sugihara, K., Kouzuma, Y., Kimura, M., and Yamasaki, N. (1999) Biochim. Biophys. Acta 1435, 167-176[CrossRef][Medline] [Order article via Infotrieve]
  22. Uchida, T., Yamasaki, T., Eto, S., Sugawara, H., Kurisu, G., Nakagawa, A., Kusunoki, M., and Hatakeyama, T. (2004) J. Biol. Chem. 279, 37133-37141[Abstract/Free Full Text]
  23. Hatakeyama, T., Matsuo, N., Shiba, K., Nishinohara, S., Yamasaki, N., Sugawara, H., and Aoyagi, H. (2002) Biosci. Biotechnol. Biochem. 66, 157-163[CrossRef][Medline] [Order article via Infotrieve]
  24. Hatakeyama, T., Matsuo, N., Aoyagi, H., Sugawara, H., Uchida, T., Kurisu, G., and Kusunoki, M. (2002) Acta Crystallogr. Sect. D 58, 143-144[CrossRef][Medline] [Order article via Infotrieve]
  25. Watanabe, N., Nakagawa, A., Adachi, S., and Sakabe, N. (1995) Rev. Sci. Instrum. 66, 1824-1826
  26. Leslie, A. G. W. (1992) Joint CCP4 + ESF-EAMCB Newsletter on Protein Crystallography 26
  27. Collaborative Computational Project, Number 4 (1994) Acta Crystallogr. Sect. D 50, 760-763[CrossRef][Medline] [Order article via Infotrieve]
  28. Matthews, B. W. (1968) J. Mol. Biol. 33, 491-497[Medline] [Order article via Infotrieve]
  29. Bertrand, J. A., Pignol, D., Bernard, J. P., Verdier, J. M., Dagorn, J. C., and Fontecilla-Camps, J. C. (1996) EMBO J. 15, 2678-2684[Medline] [Order article via Infotrieve]
  30. Navaza, J. (1994) Acta Crystallogr. Sect. A 50, 157-163[CrossRef]
  31. Brunger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Acta Cryst. Sect. D 54, 905-921[CrossRef][Medline] [Order article via Infotrieve]
  32. Brunger, A. (1997) Methods Enzymol. 277, 366-396[Medline] [Order article via Infotrieve]
  33. McRee, D. E. (1999) J. Struct. Biol. 125, 156-165[CrossRef][Medline] [Order article via Infotrieve]
  34. Murshudov, G. N., Vagin, A., and Dodson, E. (1997) Acta Crystallogr. Sect. D 53, 240-255[CrossRef][Medline] [Order article via Infotrieve]
  35. Laskowski, R., MacArthur, M., Moss, D., and Thornton, J. M. (1993) J. Appl. Crystallogr. 26, 283-291[CrossRef]
  36. Hatakeyama, T., Shiba, K., Matsuo, N., Fujimoto, T., Oda, T., Sugawara, H., and Aoyagi, H. (2004) J. Biochem. (Tokyo) 135, 101-107[Abstract/Free Full Text]
  37. Holm, L., and Sander, C. (1994) Proteins 19, 165-173[CrossRef][Medline] [Order article via Infotrieve]
  38. Drickamer, K. (1999) Curr. Opin. Struct. Biol. 9, 585-590[CrossRef][Medline] [Order article via Infotrieve]
  39. Poget, S. F., Legge, G. B., Proctor, M. R., Butler, P. J., Bycroft, M., and Williams, R. L. (1999) J. Mol. Biol. 290, 867-879[CrossRef][Medline] [Order article via Infotrieve]
  40. Mizuno, H., Fujimoto, Z., Koizumi, M., Kano, H., Atoda, H., and Morita, T. (1997) Nat. Struct. Biol. 4, 438-441[CrossRef][Medline] [Order article via Infotrieve]
  41. Mizuno, H., Fujimoto, Z., Koizumi, M., Kano, H., Atoda, H., and Morita, T. (1999) J. Mol. Biol. 289, 103-112[CrossRef][Medline] [Order article via Infotrieve]
  42. Kjell Håkansson, K., Lim, N. K., Hoppe, H. J., and Reid, K. B. (1999) Structure 7, 255-264[Medline] [Order article via Infotrieve]
  43. Kakiuchi, M., Okino, N., Sueyoshi, N., Ichinose, S., Omori, A., Kawabata, S., Yamaguchi, K., and Ito, M. (2002) Glycobiology 12, 85-94[Abstract/Free Full Text]
  44. Iobst, S. T., and Drickamer, K. (1996) J. Biol. Chem. 271, 6686-6693[Abstract/Free Full Text]
  45. Hutchinson, E. G., and Thornton, J. M. (1996) Protein Sci. 5, 212-220[Abstract]
  46. Kraulis, P. J. (1991) J. Appl. Crystallogr. 24, 946-950[CrossRef]
  47. Merritt, E., and Bacon, D. (1997) Methods Enzymol. 277, 505-524[Medline] [Order article via Infotrieve]
  48. McDonald, I. K., and Thornton, J. M. (1994) J. Mol. Biol. 238, 777-793[CrossRef][Medline] [Order article via Infotrieve]
  49. DeLano, W. L. (2002) The PyMOL Molecular Graphics Systems, DeLano Scientific, San Carlos, CA
  50. Barton, G. J. (1993) Protein Eng. 6, 37-40[Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Hatakeyama, H. Unno, Y. Kouzuma, T. Uchida, S. Eto, H. Hidemura, N. Kato, M. Yonekura, and M. Kusunoki
C-type Lectin-like Carbohydrate Recognition of the Hemolytic Lectin CEL-III Containing Ricin-type -Trefoil Folds
J. Biol. Chem., December 28, 2007; 282(52): 37826 - 37835.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
T. Kuramoto, H. Uzuyama, T. Hatakeyama, T. Tamura, T. Nakashima, K. Yamaguchi, and T. Oda
Cytotoxicity of a GalNAc-Specific C-Type Lectin CEL-I toward Various Cell Lines
J. Biochem., January 1, 2005; 137(1): 41 - 50.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/43/45219    most recent
M408840200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sugawara, H.
Right arrow Articles by Hatakeyama, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sugawara, H.
Right arrow Articles by Hatakeyama, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.